| Year |
Citation |
Score |
| 2015 |
Napier RJ, Adams EJ, Gold MC, Lewinsohn DM. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity. Frontiers in Immunology. 6: 344. PMID 26217338 DOI: 10.3389/Fimmu.2015.00344 |
0.317 |
|
| 2015 |
Napier RJ, Norris BA, Swimm A, Giver CR, Harris WA, Laval J, Napier BA, Patel G, Crump R, Peng Z, Bornmann W, Pulendran B, Buller RM, Weiss DS, Tirouvanziam R, et al. Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. Plos Pathogens. 11: e1004770. PMID 25822986 DOI: 10.1371/Journal.Ppat.1004770 |
0.424 |
|
| 2015 |
Gold MC, Napier RJ, Lewinsohn DM. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis. Immunological Reviews. 264: 154-66. PMID 25703558 DOI: 10.1111/Imr.12271 |
0.384 |
|
| 2015 |
Baldwin PR, Reeves AZ, Powell KR, Napier RJ, Swimm AI, Sun A, Giesler K, Bommarius B, Shinnick TM, Snyder JP, Liotta DC, Kalman D. Monocarbonyl analogs of curcumin inhibit growth of antibiotic sensitive and resistant strains of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 92: 693-9. PMID 25618016 DOI: 10.1016/J.Ejmech.2015.01.020 |
0.698 |
|
| 2012 |
Napier RJ, Shinnick TM, Kalman D. Back to the future: host-targeted chemotherapeutics for drug-resistant TB. Future Microbiology. 7: 431-5. PMID 22439718 DOI: 10.2217/Fmb.12.19 |
0.72 |
|
| 2011 |
Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host & Microbe. 10: 475-85. PMID 22100163 DOI: 10.1016/J.Chom.2011.09.010 |
0.313 |
|
| Show low-probability matches. |